In order to understand the difference of activated lymphocytes in peripheral blood between lung cancer patients and healthy person, we analyzed the percentages of CD69+ lymphocytes by gating CD45+CD3+CD69+ T cells and CD45+CD3-CD69+ non-T cells, respectively (Fig. 2A). This evidence concerns the gene CD69 and lung carcinoma.